Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib vs Physician's Choice in HER2- gBRCA+ Breast Cancer
NCT01905592Phase 3Terminated
- Start
- Feb 2014
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of niraparib in breast cancer. Started Feb 2014; status: terminated.
02
Drugs
niraparib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01905592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01905592.